FGF2 and Kaposi's sarcoma: Endostatin could co-localizes to tropomysin microfilaments and acts to inhibit AIDS-related Kaposi’s sarcoma (KS) cell migration and invasion in response to the clinically relevant angiogenic cytokines VEGF and bFGF [44].